Mini review: genome and transcriptome editing using CRISPR-cas systems for haematological malignancy gene therapy.

Elliott, Esther K; Haupt, Larisa M; Griffiths, Lyn R

Elliott, Esther K; Haupt, Larisa M; Griffiths, Lyn R.

Afiliación

Elliott EK; Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia.
Haupt LM; Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia.
Griffiths LR; Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia. lyn.griffiths@qut.edu.au.

Transgenic Res ; 30(2): 129-141, 2021 04.

Article en En | MEDLINE | ID: mdl-33609253

Asunto(s)

Sistemas CRISPR-Cas; Edición Génica; Ingeniería Genética/métodos; Terapia Genética/métodos; Genoma Humano; Neoplasias Hematológicas/terapia; Transcriptoma; Neoplasias Hematológicas/genética; Neoplasias Hematológicas/patología; Humanos

Palabras clave

CRISPR1; Cas4; Gene-therapy3; Genome-editing2; Malignancy6; Transcriptome5

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia Genética / Ingeniería Genética / Genoma Humano / Neoplasias Hematológicas / Transcriptoma / Sistemas CRISPR-Cas / Edición Génica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Transgenic Res Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google